Acquiring Company
Schneider Electric
Acquired Company
PTC Therapeutics
Description
Schneider Electric is nearing a $20 billion deal to acquire PTC, a US software group. The acquisition discussions are currently ongoing, with a potential announcement expected soon. PTC, based in Boston, has a market value of $15.63 billion. This acquisition highlights Schneider's commitment to expanding its software capabilities.
Fundz sees it the moment Schneider Electric makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired PTC Therapeutics?
PTC Therapeutics was acquired by Schneider Electric, based in Paris. The deal was reported on October 4, 2026. Schneider Electric is a global energy technology leader focused on providing solutions that enhance energy management and automation. Schneider Electric is privately held and operates in Manufacturing.
When did Schneider Electric acquire PTC Therapeutics?
Schneider Electric's acquisition of PTC Therapeutics was reported on October 4, 2026. Schneider Electric is nearing a $20 billion deal to acquire PTC, a US software group. The acquisition discussions are currently ongoing, with a potential announcement expected soon. PTC, based in Boston, has a market value of $15.63 billion. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does PTC Therapeutics do?
PTC Therapeutics is a biopharmaceutical company that engages in the discovery, development and commercialization of small-molecule drugs. It is publicly traded (PTCT), operating in Biotechnology, and is based in South Plainfield.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.